Texas Supreme Court Lifts Injunction, Clears Path for Delta-8 THC Ban
The ruling lets the Department of State Health Services enforce its Schedule I classification of delta-8 THC, though retailers retain the right to challenge the rule in court.
By CBDWorldNews Editorial Staff | May 15, 2026
On May 1, the Texas Supreme Court dissolved a temporary injunction that had blocked the Department of State Health Services (DSHS) from treating delta-8 THC as a Schedule I controlled substance. The decision hands state regulators the authority they have sought since 2021, though hemp retailers can still fight the classification through ongoing litigation.
Five Years of Legal Limbo
The dispute dates back to October 2021, when DSHS posted a notice on its website classifying any amount of delta-8 THC as a Schedule I substance under the Texas Controlled Substances Act. The move effectively made delta-8 products illegal overnight, without a formal rulemaking process.
Hometown Hero, a Texas-based hemp retailer, along with other companies sued DSHS, arguing the agency overstepped its authority. A lower court granted a temporary injunction blocking enforcement, and the hemp industry continued operating in a legal gray zone while the case worked its way through the system.
What the Justices Decided
The Supreme Court ruled that the DSHS commissioner had the legal authority to update the state’s controlled substances schedule to include delta-8 THC. While the justices acknowledged that the classification likely harmed hemp businesses, they concluded the injunction was not the proper remedy.
The court noted an important limitation: DSHS can only impose civil penalties under the Texas Controlled Substances Act, not criminal charges. That distinction matters for retailers and consumers who may have inventory or products on hand.
“The Department of State Health Services acted within its statutory authority. The injunction must be dissolved.”
Impact on Texas Hemp Businesses
Texas has been one of the largest markets for hemp-derived THC products, with hundreds of retailers and manufacturers building businesses around delta-8, delta-10, and similar cannabinoids. The ruling creates immediate uncertainty for those operations.
Industry groups estimate that the Texas hemp market supports thousands of jobs and generates hundreds of millions in annual revenue. With DSHS now free to enforce its classification, businesses face difficult decisions about inventory, product lines, and whether to continue operating while the underlying lawsuit proceeds.
A Double Blow: Federal and State Pressure
The timing compounds the pressure. The ruling landed the same week the White House released its 2026 National Drug Control Strategy, which explicitly names delta-8 THC and similar hemp derivatives as enforcement targets. Texas retailers now face restrictions from both state regulators and the approaching federal ban set for November 12.
For consumers who rely on hemp-derived products, understanding what’s in your CBD product through certificate of analysis verification has never been more important. Those looking for products that will remain legal under evolving regulations can explore compliant CBD options reviewed by our team at CBDProducts.com.
What Happens Now
The case is not over. Hemp retailers retain the right to challenge the DSHS classification on its merits, and additional hearings are expected in the coming months. But with the injunction dissolved, DSHS can begin enforcing its Schedule I designation while litigation continues.
The practical effect: delta-8 THC products in Texas now exist under active regulatory threat. Retailers will need to assess their risk tolerance and legal exposure as enforcement begins.
These statements have not been evaluated by the Food and Drug Administration. CBD products are not intended to diagnose, treat, cure, or prevent any disease.
